Characterization of the T cell recognition of hepatitis B surface antigen (HBsAg) by good and poor responders to hepatitis B vaccines

被引:39
作者
Desombere, I [1 ]
Gijbels, Y [1 ]
Verwulgen, A [1 ]
Leroux-Roels, G [1 ]
机构
[1] State Univ Ghent, State Univ Ghent Hosp, Ctr Vaccinol, B-9000 Ghent, Belgium
关键词
T cell epitopes; HBsAg; synthetic peptides; HLA restriction;
D O I
10.1046/j.1365-2249.2000.01383.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To study the regulation of the human cellular immune response to HBsAg we produced a series of HBsAg-specific T cell lines from good and poor responders to the hepatitis B vaccine. All T cell lines expressed CD4 on their membrane and could therefore be considered of the helper/inducer phenotype. The different HBsAg-specific T cell lines were restricted by HLA-DRB5*0101, DRB1*1201, -DRB1*0701, -DRB1*0301, -DPB1*0201, -DPB1*0402, and -DPB1*0901. In good responders to the hepatitis B vaccine different HLA molecules could act as restricting element. In poor responders the diversity of HLA class II restriction determinants was more limited. This leads us to conclude that the immune response to HBsAg is multispecific and polyclonal in good responders and paucispecific and oligoclonal in poor responders to the hepatitis B vaccine. By using a panel of synthetic peptides representing selected sequences of the HBsAg, the fine specificities of each of these T cell lines could be determined. Strikingly, the majority of the identified T cell epitopes was located in and around the first hydrophobic transmembranous region of the HBsAg. This was observed in T cell lines from good and poor vaccine responders, without distinction. The remarkable T cell immunogenicity of this region may reside in its richness in binding motifs for a variety of HLA class II determinants.
引用
收藏
页码:390 / 399
页数:10
相关论文
共 62 条
  • [1] GENETIC PREDICTION OF NONRESPONSE TO HEPATITIS-B VACCINE
    ALPER, CA
    KRUSKALL, MS
    MARCUSBAGLEY, D
    CRAVEN, DE
    KATZ, AJ
    BRINK, SJ
    DIENSTAG, JL
    AWDEH, Z
    YUNIS, EJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (11) : 708 - 712
  • [2] ANDRE FE, 1987, POSTGRAD MED J, V63, P169
  • [3] BINDING OF IMMUNOGENIC PEPTIDES TO IA HISTOCOMPATIBILITY MOLECULES
    BABBITT, BP
    ALLEN, PM
    MATSUEDA, G
    HABER, E
    UNANUE, ER
    [J]. NATURE, 1985, 317 (6035) : 359 - 361
  • [4] BARNABA V, 1994, J IMMUNOL, V152, P3074
  • [5] Nomenclature for factors of the HLA system, 1996
    Bodmer, JG
    Marsh, SGE
    Albert, ED
    Bodmer, WF
    Bontrop, RE
    Charron, D
    Dupont, B
    Erlich, HA
    Fauchet, R
    Mach, B
    Mayr, WR
    Parham, P
    Sasazuki, T
    Schreuder, GMT
    Strominger, JL
    Svejgaard, A
    Terasaki, PI
    [J]. TISSUE ANTIGENS, 1997, 49 (03): : 297 - 321
  • [6] THE RELATION BETWEEN MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) RESTRICTION AND THE CAPACITY OF IA TO BIND IMMUNOGENIC PEPTIDES
    BUUS, S
    SETTE, A
    COLON, SM
    MILES, C
    GREY, HM
    [J]. SCIENCE, 1987, 235 (4794) : 1353 - 1358
  • [7] RAPID DNA TYPING OF CLASS-II HLA ANTIGENS USING THE POLYMERASE CHAIN-REACTION AND REVERSE DOT BLOT HYBRIDIZATION
    BUYSE, I
    DECORTE, R
    BAENS, M
    CUPPENS, H
    SEMANA, G
    EMONDS, MP
    MARYNEN, P
    CASSIMAN, JJ
    [J]. TISSUE ANTIGENS, 1993, 41 (01): : 1 - 14
  • [8] CABEZON T, 1990, VACCINES 90, P199
  • [9] CELIS E, 1988, J IMMUNOL, V140, P1808
  • [10] PRESENTATION OF AN IMMUNODOMINANT T-CELL EPITOPE OF HEPATITIS-B SURFACE-ANTIGEN BY THE HLA-DPW4 MOLECULE
    CELIS, E
    KARR, RW
    [J]. JOURNAL OF VIROLOGY, 1989, 63 (02) : 747 - 752